Litcius/Paper detail

Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study

Robert Carroll, Michael Boyer, Val Gebski, Bronwyn Hockley, Julie Johnston, Svjetlana Kireta, Hsiang Tan, Anne E. Taylor, Kate Wyburn, John Zalcberg

2022The Lancet Oncology87 citationsDOI

Topics & Concepts

MedicineImmunosuppressionNivolumabInternal medicinePopulationClinical endpointKidney cancerCreatinineOncologyClinical trialCancerImmunotherapyEnvironmental healthViral-associated cancers and disordersRenal cell carcinoma treatmentRenal Transplantation Outcomes and Treatments